Advertisement

TGF-β in Human Disease

  • Aristidis Moustakas
  • Keiji Miyazawa

Table of contents

  1. Front Matter
    Pages i-viii
  2. Introduction

    1. Front Matter
      Pages 1-1
    2. Carl-Henrik Heldin
      Pages 3-32
    3. Zhongwei Li, Danny Huylebroeck, Ye-Guang Chen
      Pages 33-58
    4. Alison E. Meyer, Karthikeyan Mythreye, Gerard C. Blobe
      Pages 59-89
  3. Cancer, Fibrosis, and Inflammation

    1. Front Matter
      Pages 91-91
    2. Hiroaki Ikushima, Kohei Miyazono
      Pages 93-112
    3. Laurent Bartholin, David F. Vincent, Ulrich Valcourt
      Pages 113-138
    4. Ulrich Valcourt, David F. Vincent, Laurent Bartholin
      Pages 139-168
    5. Michael K. Wendt, William P. Schiemann
      Pages 169-187
    6. Kazuhito Naka, Atsushi Hirao
      Pages 189-207
    7. Gangwen Han, Zheyi Han, Xiao-Jing Wang
      Pages 209-233
    8. Delphine Javelaud, Alain Mauviel
      Pages 235-254
    9. Isabel Fabregat, Patricia Sancho
      Pages 255-277
    10. Seong-Jin Kim, Seok Hee Park
      Pages 279-294
  4. Cardiovascular Diseases

    1. Front Matter
      Pages 295-295
    2. Laurens A. van Meeteren, Marie-José Goumans, Peter ten Dijke
      Pages 297-322
    3. Sara I. Cunha, Kristian Pietras
      Pages 323-348
  5. Other Diseases

    1. Front Matter
      Pages 369-369
    2. Shiro Ikegawa, Mitsuko Nakashima, Naomichi Matsumoto
      Pages 371-390
    3. Kerstin Krieglstein
      Pages 391-412
    4. Grace Bennett, Sushil G. Rane
      Pages 413-431
  6. Disease Prognosis and Therapy

    1. Front Matter
      Pages 433-433
    2. Kristian Pietras, Sara I. Cunha
      Pages 435-458
  7. Back Matter
    Pages 459-464

About this book

Introduction

Transforming growth factor-β (TGF-β) is a secreted polypeptide with multifunctional properties manifested during embryonic development, adult organ physiology, and pathobiology of major diseases, including cancer and fibrotic and cardiovascular diseases. The signaling pathway of TGF-β now is rather well understood. Continuing revelations in the mechanisms of action of TGF-β provide specific mechanistic examples of how human cells lose their controlled function and behave wrongly during the development of diverse diseases. Equally important, however, is the current promise of exploiting the TGF-β pathway in combating human disease. This book comprehensively covers major areas of human disease where the involvement of TGF-β is firmly established. Simultaneously, the book highlights major gaps in knowledge and the future directions of research that can benefit human medical science. The core set of diseases where TGF-β action is well documented and are included in the book are cancer and cardiovascular and fibrotic disorders. The central aim of the book is to stimulate young scientists to enter the prolific TGF-β field and find new solutions to the problems remaining in this area of study. For this purpose the book provides authoritative educational chapters that furnish a good introduction to the field for young doctoral students, postdocs, and clinical fellows. The book also serves as a valuable reference for the aficionados in the field, who can find accessible and well-illustrated material for their teaching and lecturing activities, via which the importance of TGF-β biology is disseminated to the world of science and to the public.

Keywords

Cancer Cardiovascular diseases Fibrotic diseases Inflammatory diseases Transforming growth factor-β

Editors and affiliations

  • Aristidis Moustakas
    • 1
  • Keiji Miyazawa
    • 2
  1. 1., Dept Medical Biochem MicrobiolUppsala UniversityUppsalaSweden
  2. 2., Interdiscip. Grad. Sch. Med. Eng.University of YamanashiChuoJapan

Bibliographic information

Industry Sectors
Pharma
Consumer Packaged Goods